The Multiple Sclerosis Functional Composite: A new clinical outcome measure for multiple sclerosis trials

Multiple Sclerosis

Volumn 8, Issue 5, 2002, Pages 359-365

  Rudick, R A ^a   Cutter, G ^b   Reingold, S ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c National Multiple Sclerosis Society   (United States)

Author keywords

Clinical trials; EDSS; Multiple sclerosis; Multiple sclerosis functional composite; Outcome measures

Indexed keywords

BETA1A INTERFERON; PLACEBO;

ARM MOVEMENT; BRAIN ATROPHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; CORRELATION ANALYSIS; DATA ANALYSIS; DISABILITY; DISEASE CONTROL; DISEASE COURSE; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; MEDICAL INFORMATION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; QUALITY OF LIFE; RATING SCALE; REPRODUCIBILITY; REVIEW; SAMPLE SIZE; SELF REPORT; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STATISTICAL SIGNIFICANCE; WALKING;

CLINICAL TRIALS; DISABILITY EVALUATION; HUMANS; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS;

EID: 0036783422     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458502ms845oa     Document Type: Review

References (24)

1. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force
2. Outcomes assessment in multiple sclerosis clinical trials: A critical analysis
3. Kurtzke scales revisited: The application of psychometric methods to clinical intuition
4. Clinical outcomes assessment in multiple sclerosis
5. Development of a multiple sclerosis functional composite as a clinical trial outcome measure
6. Upper extremity function in multiple sclerosis: Improving assessment sensitivity with box-and-block and nine-hole peg tests
7. Paced Auditory Serial-Addition Task: A measure of recovery from concussion
8. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
9. The natural history of multiple sclerosis: A geographically based study. 4 Applications to planning and interpretation of clinical therapeutic trials
10. The measurement of ambulatory impairment in multiple sclerosis
11. Intrarater and interrater reliability of the MS functional composite outcome measure
12. Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial
13. New low-contrast vision charts: Reliability and test characteristics in patients with multiple sclerosis
14. Performance of a visual function test in a multiple sclerosis cohort
15. MS functional composite. Relation to disease phenotype and disability strata
16. Concurrent validity of the MS functional composite using MRI as a biological disease marker
17. Optimizing the association between disability and biological markers in MS
18. Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patients
19. Clinical significance of the Multiple Sclerosis Functional Composite: Relationship to patient-reported quality of life
20. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS
21. Comparison of full-field digital mammography with screen-film mammography for cancer detection: Results of 4, 945 paired examinations
22. Predictive validity of the MS functional composite in progressive MS
23. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project